Ibuzatrelvir and Remdesivir Trial for Immunocompromised COVID-19 Patients in LA
Recent clinical investigations being evaluated in early trial phases focus on the evaluation of ibuzatrelvir, administered both as a monotherapy and in combination with remdesivir, for treating symptomatic COVID-19 in ... Read More